Why the study?
Are EDTA samples stable for prothrombin time measurement using the combined thromboplastin reagent?
Are EDTA samples stable for prothrombin time measurement using the combined thromboplastin reagent?
EDTA samples are stable for PT measurement using the combined thromboplastin reagent, highlighting the importance of tube material in preventing artifactual factor VII activation.
Answers are grounded in this paper and cite their sources.
EDTA tubes may avoid artifactual PT shortening from cold-activated factor VII; leaves open validation across reagents and lab conditions.
The prothrombin time (PT) test is used to detect preoperative bleeding tendencies and to monitor anticoagulant therapy (prevention of venous thromboembolism, treatment of deep vein thrombosis, primary prevention of myocardial ischemia, acute myocardial infarction, prosthetic heart valves, atrial fibrillation, and other indications) (1). Anticoagulant therapy is widely used, and requests for PT tests are increasing continually (2). Two major methods are used worldwide to measure PT, namely the “Quick method” and the Owren method (combined thromboplastin reagent). Properties of these methods were compared in a recent study (3). Most studies in the scientific literature have used the Quick method, and the results do not always correspond to the combined thromboplastin method. The materials of which evacuated tubes are constructed affect the stability of samples for PT assay. The surface of borosilicate glass activates factor VII at 4 °C, which shortens the coagulation time(s) for PT (4)(5). In polypropylene or siliconized borosilicate glass tubes, surface activation is lower.
No takes yet. Share an insight, caveat, or question.
Juha Horsti (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: